Gansu Province's first Chinese medicine industry innovation consortium was approved

New Gansu client Lanzhou News (New Gansu · Gansu Daily reporter Zhang Yanru) Reporter learned from the Provincial Department of Science and Technology that recently, Gansu ’s Chinese Medicine Industry Innovation Federation has officially obtained the filing. The consortium was jointly established by 39 units including Gansu Pharmaceutical Investment Group, medical institutions, scientific research institutes, and Chinese medicine enterprises. With the support of the Gansu Provincial Department of Science and Technology and the Gansu Provincial Department of Industry and Information Technology, Multiple rounds of expert consultation lasted about half a year, and finally obtained the filing.

Data map.

As an important part of the biomedical industry, the Chinese medicine industry is a key industry chain in Gansu. Over the years, Gansu has centralized deployment for policy leadership, platform construction, R & D and production, and expanding financing channels to help the high -quality development of the Chinese medicine industry. At present, the annual output value of the full industrial chain of the Chinese medicinal material chain of Gansu Province is 52 billion yuan, the annual output value of Chinese medicine production enterprises is more than 1 billion yuan, 3 more than 500 million yuan, 21 million yuan or more, and the sales of more than 100 million yuan This, the resources of Chinese medicinal materials are rich, and have a relatively solid foundation for innovative research and development.

The establishment of an innovation consortium in the field of Chinese medicine aims to strengthen the interconnection and interconnection between colleges and universities, scientific research institutes, pharmaceutical companies, and medical institutions in the province. Research on major common technologies and key technologies, promote the integration of the talent chain, industrial chain, project chain, technology chain, and capital chain of various units in the joint body to explore a set of government guidance, enterprise issues, multi -party funding, science and enterprises and enterprises. The new type of collaborative innovation mechanism shared by research and achievements will improve the modernization level of the Chinese medicine industry chain in our province, continue to promote the integration of high -quality resources in the Gansu traditional Chinese medicine industry, transform the advantages of traditional Chinese medicine resources into economic advantages, and enhance the core competitiveness of Gansu Province's biomedical industry Essence

- END -